Butterfly Network Inc
BFLY1.435USD
+0.035+2.50%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
360.24MCap. mercado
PérdidaP/E TTM
Más Datos de Butterfly Network Inc Compañía
Butterfly Network, Inc. is a digital health company. The Company is focused on transforming care through a combination of portable, semiconductor-based ultrasound technology, intuitive software, services, and educational offerings. It has two portable ultrasound devices on the market: second-generation Butterfly iQ+ and third-generation Butterfly iQ3. Butterfly iQ+/iQ3 are both powered by its Ultrasound-on-Chip technology, allowing them to power whole-body imaging on a single handheld probe using digital semiconductor technology. It offers cloud-based software solutions to healthcare systems, teleguidance, in-app educational tutorials, formal education programs through its Butterfly Academy software and Butterfly Certified courses, as well as professional services for large scale deployments. Within the Butterfly application, users can utilize up to six imaging modes, including B-Mode, Color Doppler, M-Mode, Power Doppler, Pulsed-Wave Doppler, and Biplane Imaging.
Información de la empresa
Símbolo de cotizaciónBFLY
Nombre de la empresaButterfly Network Inc
Fecha de salida a bolsaMay 26, 2020
Director ejecutivoDr. Joseph M. (Joe) Devivo
Número de empleados190
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 26
Dirección1600 District Avenue
CiudadBURLINGTON
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal01803
Teléfono17815574800
Sitio Webhttps://www.butterflynetwork.com/
Símbolo de cotizaciónBFLY
Fecha de salida a bolsaMay 26, 2020
Director ejecutivoDr. Joseph M. (Joe) Devivo
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Dr. Elazer Edelman, M.D., Ph.D.
Dr. Elazer Edelman, M.D., Ph.D.
Independent Director
Independent Director
--
--
Dr. Erica G. Schwartz, M.D., J.D.
Dr. Erica G. Schwartz, M.D., J.D.
Independent Director
Independent Director
--
--
Ms. S. Louise Phanstiel, CPA
Ms. S. Louise Phanstiel, CPA
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Jonathan M. Rothberg, Ph.D.
Dr. Jonathan M. Rothberg, Ph.D.
Director
Director
9.65M
+0.84%
Dr. Joseph M. (Joe) Devivo
Dr. Joseph M. (Joe) Devivo
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
2.43M
+67.94%
Mr. Steve Cashman
Mr. Steve Cashman
Chief Business Officer
Chief Business Officer
502.59K
-77.90%
Mr. Larry Robbins
Mr. Larry Robbins
Lead Independent Director
Lead Independent Director
365.50K
+187.40%
Ms. Dawn Carfora
Ms. Dawn Carfora
Independent Director
Independent Director
219.62K
+57.79%
Dr. Andrei G. Stoica, Ph.D.
Dr. Andrei G. Stoica, Ph.D.
Chief Technology Officer
Chief Technology Officer
--
--
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
Por negocioUSD
Nombre
Ganancia
Proporción
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
17.04M
80.28%
International
4.19M
19.72%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Hardware
14.16M
66.73%
Software and other services
7.06M
33.27%
Estadísticas de accionistas
Actualizado: jue., 22 de may
Actualizado: jue., 22 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Accionistas
Accionistas
Proporción
Fosun International Ltd
4.85%
Glenview Capital Management, LLC
4.51%
Rothberg (Jonathan M)
4.37%
The Vanguard Group, Inc.
3.88%
Capital Research Global Investors
3.84%
Other
78.55%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
24.01%
Hedge Fund
10.38%
Investment Advisor/Hedge Fund
8.67%
Individual Investor
6.98%
Holding Company
4.85%
Corporation
2.06%
Research Firm
2.03%
Foundation
0.46%
Pension Fund
0.31%
Other
40.26%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
452
132.08M
59.80%
+19.64M
2025Q1
463
134.83M
61.70%
+30.88M
2024Q4
439
95.60M
44.26%
+1.75M
2024Q3
436
81.98M
42.82%
-15.90M
2024Q2
437
84.70M
45.43%
-25.58M
2024Q1
443
102.66M
55.89%
-10.36M
2023Q4
445
101.26M
55.91%
-15.86M
2023Q3
456
105.48M
58.39%
-19.66M
2023Q2
472
110.05M
61.35%
-5.29M
2023Q1
486
98.46M
55.67%
-23.16M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fosun International Ltd
10.72M
4.85%
--
--
Mar 31, 2025
Glenview Capital Management, LLC
9.96M
4.51%
--
--
Jun 13, 2025
Rothberg (Jonathan M)
9.65M
4.37%
+80.43K
+0.84%
Jun 13, 2025
The Vanguard Group, Inc.
8.57M
3.88%
+1.13M
+15.21%
Mar 31, 2025
Capital Research Global Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
Capital World Investors
8.49M
3.84%
+7.13M
+524.60%
Mar 31, 2025
ARK Investment Management LLC
7.02M
3.18%
+1.01M
+16.84%
Mar 31, 2025
First Light Asset Management, LLC
5.51M
2.49%
+1.51M
+37.83%
Mar 31, 2025
Hood River Capital Management LLC
4.95M
2.24%
+4.95M
--
Mar 31, 2025
Longview Investors LLC
4.55M
2.06%
--
--
Jun 13, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 2 de ago
Actualizado: sáb., 2 de ago
Nombre
Proporción
ARK Genomic Revolution ETF
1.23%
SPDR S&P Health Care Equipment ETF
0.81%
Global X HealthTech ETF
0.37%
SPDR S&P Kensho New Economies Composite ETF
0.16%
iShares Micro-Cap ETF
0.09%
iShares U.S. Medical Devices ETF
0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.03%
iShares Russell 2000 Growth ETF
0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
0.03%
Global X Russell 2000 ETF
0.02%
Ver más
ARK Genomic Revolution ETF
Proporción1.23%
SPDR S&P Health Care Equipment ETF
Proporción0.81%
Global X HealthTech ETF
Proporción0.37%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.16%
iShares Micro-Cap ETF
Proporción0.09%
iShares U.S. Medical Devices ETF
Proporción0.04%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.03%
iShares Russell 2000 Growth ETF
Proporción0.03%
Invesco Russell 2000 Dynamic Multifactor ETF
Proporción0.03%
Global X Russell 2000 ETF
Proporción0.02%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
